Skip to main content
SpringerLink
Log in
Book cover

Cancer du sein pp 435–440Cite as

Outils génomiques du choix thérapeutique des cancers du sein. Quelles perspectives à court et moyen terme sur le traitement locorégional. Opinion du radiothérapeute?

  • Conference paper

  • 537 Accesses

Résumé

En France, le cancer du sein est le plus fréquent chez la femme avec une incidence qui ne cesse d’augmenter depuis les deux dernières décennies avec cependant une mortalité à la baisse [1]. Le dépistage systématique a permis un diagnostic d’un nombre plus élevé de cancers du sein de stade précoce et potentiellement curables.

This is a preview of subscription content, log in via an institution.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Références

  1. Belot A, Grosclaude P, Bossard N et al. (2008) Cancer incidence and mortality in France over the period 1980-2005. Rev Epidemiol Sante Publique 56: 159–175

    Article  PubMed  CAS  Google Scholar 

  2. Perou CM, Sørlie T, Eisen MB et al. (2000) Molecular portraits of human breast tumours. Nature 406: 747–752

    Article  PubMed  CAS  Google Scholar 

  3. Sørlie T, Perou CM, Tibshirani R et al. (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98: 10869–10874

    Article  PubMed  Google Scholar 

  4. van’ t Veer LJ, Dai H, van de Vijver MJ et al. (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415: 530–536

    Article  Google Scholar 

  5. Paik S, Shak S, Tang G et al. (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351: 2817–2826

    Article  PubMed  CAS  Google Scholar 

  6. Wang Y, Klijn JG, Zhang Y et al. (2005) Gene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancer. Lancet 365: 671–679

    PubMed  CAS  Google Scholar 

  7. Chang HY, Nuyten DS, Sneddon JB et al. (2005) Robustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survival. Proc Natl Acad Sci USA 102: 3738–3743

    Article  PubMed  CAS  Google Scholar 

  8. Liu R, Wang X, Chen GY et al. (2007) The prognostic role of a gene signature from tumorigenic breast-cancer cells. N Engl J Med 356: 217–226

    Article  PubMed  CAS  Google Scholar 

  9. van Beers EH, Nederlof PM (2006) Array-CGH and breast cancer. Breast Cancer Res 8: 210

    Article  PubMed  Google Scholar 

  10. Khodarev NN, Beckett M, Labay E et al. (2004) STAT1 is overexpressed in tumors selected for radioresistance and confers protection from radiation in transduced sensitive cells. Proc Natl Acad Sci USA 101: 1714–1719

    Article  PubMed  CAS  Google Scholar 

  11. Clarke M, Collins R, Darby S et al. (2005) Effects of radiotherapy and of differences in the extent of surgery for early breast cancer on local recurrence and 15-year survival: an overview of the randomised trials. Lancet 366: 2087–2106

    PubMed  CAS  Google Scholar 

  12. Bartelink H, Horiot JC, Poortmans P et al. (2001) Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Engl J Med 345: 1378–1387

    Article  PubMed  CAS  Google Scholar 

  13. Dilhuydy JM, Bussieres E, Romestaing P (2001) Radiotherapy of the breast and chest wall: treatment volume. Cancer Radiother 5: 550–559

    Article  PubMed  CAS  Google Scholar 

  14. Fernando IN, Ford HT, Powles TJ et al. (1996) Factors affecting acute skin toxicity in patients having breast irradiation after conservative surgery: a prospective study of treatment practice at the Royal Marsden Hospital. Clin Oncol (R Coll Radiol) 8: 226–233

    Article  CAS  Google Scholar 

  15. Karlsson P, Cole BF, Price KN et al. (2007) The role of the number of uninvolved lymph nodes in predicting locoregional recurrence in breast cancer. J Clin Oncol 25: 2019–2026.

    Article  PubMed  Google Scholar 

  16. Vicini FA, Kestin L, Huang R et al. (2003) Does local recurrence affect the rate of distant metastases and survival in patients with early-stage breast carcinoma treated with breast-conserving therapy? Cancer 97: 910–919

    Article  PubMed  Google Scholar 

  17. Elkhuizen PH, van de Vijver MJ, Hermans J et al. (1998) Local recurrence after breastconserving therapy for invasive breast cancer: high incidence in young patients and association with poor survival. Int J Radiat Oncol Biol Phys 40: 859–867

    Article  PubMed  CAS  Google Scholar 

  18. Arriagada R, Lê MG, Contesso G et al. (2002) Predictive factors for local recurrence in 2006 patients with surgically resected small breast cancer. Ann Oncol 13: 1404–413

    Article  PubMed  CAS  Google Scholar 

  19. Arriagada R, Le MG, Guinebretiere JM et al. (2003) Late local recurrences in a randomised trial comparing conservative treatment with total mastectomy in early breast cancer patients. Ann Oncol 14: 1617–1622

    Article  PubMed  CAS  Google Scholar 

  20. Huston TL, Simmons RM (2005) Locally recurrent breast cancer after conservation therapy. Am J Surg 189: 229–235

    Article  PubMed  Google Scholar 

  21. Clarke DH, Lê MG, Sarrazin D et al. (1985) Analysis of local-regional relapses in patients with early breast cancers treated by excision and radiotherapy: experience of the Institut Gustave-Roussy. Int J Radiat Oncol Biol Phys 11: 137–145

    Article  PubMed  CAS  Google Scholar 

  22. Fourquet A, Campana F, Zafrani B et al. (1989) Prognostic factors of breast recurrence in the conservative management of early breast cancer: a 25-year follow-up. Int J Radiat Oncol Biol Phys 17: 719–725

    Article  PubMed  CAS  Google Scholar 

  23. Fisher B, Anderson S, Fisher ER et al. (1991) Significance of ipsilateral breast tumour recurrence after lumpectomy. Lancet 338: 327–331

    Article  PubMed  CAS  Google Scholar 

  24. Locker AP, Ellis IO, Morgan DA et al. (1989) Factors influencing local recurrence after excision and radiotherapy for primary breast cancer. Br J Surg 76: 890–894

    Article  PubMed  CAS  Google Scholar 

  25. Dragun, A.E, Pan J, Rai SN, Kruse B, Jain D (2011) Locoregional Recurrence in Patients With Triple-Negative Breast Cancer: Preliminary Results of a Single Institution Study. Am J Clin Oncol (in press)

    Google Scholar 

  26. Wang SL, Li YX, Song YW et al. (2011) Triple-Negative or HER2-Positive Status Predicts Higher Rates of Locoregional Recurrence in Node-Positive Breast Cancer Patients After Mastectomy. Int J Radiat Oncol Biol Phys (in press)

    Google Scholar 

  27. Solin LJ, Hwang WT, Vapiwala N (2009) Outcome after breast conservation treatment with radiation for women with triple-negative early-stage invasive breast carcinoma. Clin Breast Cancer 9: 96–100

    Article  PubMed  Google Scholar 

  28. Parikh RR, Yang Q, Higgins SA, Haffty BG (2008) Outcomes in young women with breast cancer of triple-negative phenotype: the prognostic significance of CK19 expression. Int J Radiat Oncol Biol Phys 70: 35–42

    Article  PubMed  Google Scholar 

  29. Freedman GM, Anderson PR, Tianyu L, Nicolaou N (2009) Locoregional recurrence of triple-negative breast cancer after breast-conserving surgery and radiation. Cancer 115: 946–951

    Article  PubMed  Google Scholar 

  30. Bourgier C et al. (2006) Molecular subclassification and risk of locoregional relapses in early breast cancer patients. San Antonio Breast Cancer Symposium Annual Meeting. Personal Communication, 2006. Abstract 6028.

    Google Scholar 

  31. Truong PT, Lesperance M, Sanghani M et al. (2008) Independent Validation of IBTR ! A Computer-based Tool to Predict Ipsilateral Breast Recurrence in Women with Invasive Breast Cancer Treated with Breast Conserving Surgery. Int J Radiat Oncol Biol Phys 72: #203

    Google Scholar 

  32. Sanghani M, Truong PT, Raad RA et al. (2008) Validation of a Web-based Predictive Nomogram for Ipsilateral Breast Tumor Recurrence after Breast Conserving Therapy. Int J Radiat Oncol Biol Phys 72: S91

    Article  Google Scholar 

  33. Nuyten DS, Kreike B, Hart AA et al. (2006) Predicting a local recurrence after breastconserving therapy by gene expression profiling. Breast Cancer Res 8: R62

    Article  Google Scholar 

  34. Weichselbaum RR, Ishwaran H, Yoon T et al. (2008) An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer. Proc Natl Acad Sci USA 105: 18490–18495

    Article  PubMed  CAS  Google Scholar 

  35. Kreike B, Halfwerk H, Armstrong N et al. (2009) Local recurrence after breastconserving therapy in relation to gene expression patterns in a large series of patients. Clin Cancer Res 1512: 4181–4190

    Article  Google Scholar 

  36. Nguyen PL, Taghian AG, Katz MS et al. (2008) Breast cancer subtype approximated by estrogen receptor, progesterone receptor, and HER-2 is associated with local and distant recurrence after breast-conserving therapy. J Clin Oncol 26: 2373–2378

    Article  PubMed  Google Scholar 

  37. Liang K, Lu Y, Jin W et al. (2003) Sensitization of breast cancer cells to radiation by trastuzumab. Mol Cancer Ther 2: 1113–1120

    PubMed  CAS  Google Scholar 

  38. Pietras RJ, Poen JC, Gallardo D et al. (1999) Monoclonal antibody to HER-2/ neureceptor modulates repair of radiation-induced DNA damage and enhances radiosensitivity of human breast cancer cells overexpressing this oncogene. Cancer Res 59: 1347–1355

    PubMed  CAS  Google Scholar 

  39. Sambade MJ, Kimple RJ, Camp JT et al. (2010) Lapatinib in combination with radiation diminishes tumor regrowth in HER2+ and basal-like/EGFR+ breast tumor xenografts. Int J Radiat Oncol Biol Phys 77: 575–581

    Article  PubMed  CAS  Google Scholar 

  40. Sambade MJ, Camp JT, Kimple RJ et al. (2009) Mechanism of lapatinib-mediated radiosensitization of breast cancer cells is primarily by inhibition of the Raf>MEK>ERK mitogen-activated protein kinase cascade and radiosensitization of lapatinib-resistant cells restored by direct inhibition of MEK. Radiother Oncol 93: 639–644

    Article  PubMed  CAS  Google Scholar 

  41. Horton JK, Halle J, Ferraro M et al. (2010) Radiosensitization of Chemotherapy-Refractory, Locally Advanced or Locally Recurrent Breast Cancer with Trastuzumab: A Phase II Trial. Int J Radiat Oncol Biol Phys 76: 998–1004

    Article  PubMed  CAS  Google Scholar 

  42. Collette S, Collette L, Budiharto T et al. (2008) Predictors of the risk of fibrosis at 10 years after breast conserving therapy for early breast cancer: a study based on the EORTC Trial 22881-10882 ‘boost versus no boost’. Eur J Cancer 44: 2587–2599

    Article  PubMed  Google Scholar 

  43. Ozsahin M, Ozsahin H, Shi Y et al. (1997) Rapid assay of intrinsic radiosensitivity based on apoptosis in human CD4 and CD8 T-lymphocytes. Int J Radiat Oncol Biol Phys 38: 429–440

    Article  PubMed  CAS  Google Scholar 

  44. Crompton NE, Shi YQ, Emery GC et al. (2001) Sources of variation in patient response to radiation treatment. Int J Radiat Oncol Biol Phys 49: 547–554

    Article  PubMed  CAS  Google Scholar 

  45. Slonina D, Gasinska A (1997) Intrinsic radiosensitivity of healthy donors and cancer patients as determined by the lymphocyte micronucleus assay. Int J Radiat Biol 72: 693–701

    Article  PubMed  CAS  Google Scholar 

  46. Azria D, Ozsahin M, Kramar A et al. (2008) Single nucleotide polymorphisms, apoptosis, and the development of severe late adverse effects after radiotherapy. Clin Cancer Res 14: 6284–6288

    Article  PubMed  CAS  Google Scholar 

  47. Ozsahin M, Crompton NEA, Gourgou S et al. (2005) 2005CD4 and CD8 T-lymphocyte apoptosis can predict radiation-induced late toxicity: a prospective study in 399 patients. Clin Cancer Res 11: 7426–7433

    Article  PubMed  CAS  Google Scholar 

Download references

Authors
  1. C. Bourgier
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer-Verlag France, Paris

About this paper

Cite this paper

Bourgier, C. (2012). Outils génomiques du choix thérapeutique des cancers du sein. Quelles perspectives à court et moyen terme sur le traitement locorégional. Opinion du radiothérapeute?. In: Cancer du sein. Springer, Paris. https://doi.org/10.1007/978-2-8178-0245-9_27

Download citation

  • DOI: https://doi.org/10.1007/978-2-8178-0245-9_27

  • Publisher Name: Springer, Paris

  • Print ISBN: 978-2-8178-0244-2

  • Online ISBN: 978-2-8178-0245-9

Publish with us

Policies and ethics

Search

Navigation